Navenibart Demonstrates Durable Efficacy and Tolerability Across Biological Sexes: Subgroup Analysis from the ALPHA-STAR Trial

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Karl V. Sitz, Michael Manning, William Lumry, Adil Adatia, William Yang, Joshua Jacobs, Theodora Cohen, Jessica M. Best, Christopher J. Morabito, Aleena Banerji
DOI: 10.1016/j.jaci.2025.12.066
Cited by: 0

Fields of Study & Subjects

Allergic Rhinitis and Sensitization Asthma and respiratory diseases Dermatology and Skin Diseases

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB21–AB21
Publication date
1 February 2026
Language
EN